The impact of human reservoir of malaria at a community-level on individual malaria occurrence in a low malaria transmission setting along the Thai-Myanmar border
© Lawpoolsri et al; licensee BioMed Central Ltd. 2010
Received: 12 March 2010
Accepted: 26 May 2010
Published: 26 May 2010
The probability of contracting malaria in a given individual is determined not only by the individual's characteristics, but also the ecological factors that characterize the level of human-vector contact in the population. Examination of the relationship between "individual" and "supra-individual" variables over time is important for understanding the local malaria epidemiology. This is essential for planning effective intervention strategies specifically for each location.
A retrospective cohort study was conducted, which followed a community-cohort of about 3,500 residents in seven hamlets along the Thai-Myanmar border between 1999 and 2006. Potential malaria determinants measured at different levels (temporal variables, individual variables, and hamlet variables) were incorporated into multilevel models to estimate their effects on an individual's risk of malaria attack.
The monthly minimum temperature was significantly associated with the seasonal variation of malaria risk. An individual risk of malaria attack decreased by about 50% during the period that active surveillance was conducted; an additional 15% and 25% reduction of Plasmodium falciparum and Plasmodium vivax incidence, respectively, was observed after the use of artesunate-mefloquine combination therapy (ACT) for treatment of P. falciparum. Male children (age < 16 years old) were at highest risk of both P. falciparum and P. vivax attack. An increase in the hamlet's incidence of P. falciparum and P. vivax by 1 per 100 persons in a previous month resulted in 1.14 and 1.34 times increase in the risk of P. falciparum and P. vivax, respectively, among individuals in a particular hamlet.
In a small area with low malaria transmission intensity, the variation in mosquito abundance is relatively similar across the residential areas; incidence of malaria between hamlets, which reflects the community level of human infectious reservoirs, is an important predictor for the malaria risk among individuals within these hamlets. Therefore, local malaria control strategies should focus on interventions that aim to reduce the gametocyte carriage in the population, such as early detection and treatment programmes and the use of ACT for P. falciparum.
Transmission of malaria is a dynamic process that involves human, vector, parasite, and environment. In addition, ecological factors, such as transmission intensity, and effectiveness of control efforts, also have a major impact on parasite transmission and malaria burden . The risk of contracting disease for a given individual is greatly affected by factors at community-level, such as level of immunity or disease in the population, environmental conditions, culture, and general contact patterns among individuals in the same group or cluster [2, 3].
Although the malaria risk factors at community-level, such as vegetation levels, immunity levels, and control programmes, have been widely studied in malaria research, these studies are generally interested in the aggregated outcomes, such as the overall incidence within specified clusters or areas; their results can be confounded by the variability among individuals within clusters and may not reflect the actual risk in an individual [3, 4]. On the other hand, an individual-level study that does not take into account the contextual components may miss important disease determinants . While the relations between individual and ecological determinants are of particular interest for understanding malaria epidemiology, it is important to simultaneously incorporate factors defined at multiple levels in epidemiological analysis.
The relative importance of specific individual-and community-level factors is likely to differ in areas of hyper-and hypo-endemicity. For example, in high malaria transmission areas, individual immune status, leading to asymptomatic infection in adults, and competent and efficient malaria vectors play an important role in malaria transmission and malaria clinical episodes [1, 6]. Therefore, environmental conditions, such as altitude, rainfall, humidity, and temperature, which affect the vector density, could have a substantial impact on malaria transmission in these hyper-endemic areas . On the other hand, in low malaria transmission areas, mosquito vectors are usually less efficient and a large fraction of population is susceptible to the disease. Not only optimal environmental conditions, spatially and temporally, favoring for vector are required for the transmission, but also density of infectious individuals in the population may become a significant determinant for sustaining the transmission in the areas [7–10]. However, studies that examine the effect of the changes in density of human reservoir at community level on the individual risk of malaria have not been established in malaria low-transmission areas.
The objective of the present study was to examine the effect of potential malaria risk factors at both community-level and individual-level factors on individual malaria risk during an 8-year period in a small geographical area along the Thai-Myanmar border.
Study site and study population
Plasmodium falciparum and Plasmodium vivax are the most common cause of malaria in the area. Although this area is classified as a low malaria transmission area, malaria accounted for about 10% of all fever cases presented at a local malaria clinic . The early detection and prompt treatment through passive surveillance was the main malaria control program in the area, since the malaria clinic was established in 1997. An additional active surveillance program that sampled more than half of the population in all hamlets each time has been conducted every three to four months since 2003. Asymptomatic infection was occasionally detected by a routine active surveillance programme during the early phase of the programme, about 1% of samples in 2003. Asymptomatic infection was rarely detected since year 2005. A single dose of mefloquine 750 mg and primaquine 30 mg, adjusting for age, was used as the first-line drug for treatment of uncomplicated P. falciparum malaria until the year 2005; because of the increased mefloquine resistance (efficacy less than 85%), the standard regimen was changed to artesunate-mefloquine combination therapy (mefloquine 750 mg. and artesunate 300 mg, followed by mefloquine 500 mg at 6 hour intervals on day 1). The standard regimen (chloroquine 1500 mg. base over 3 days combined with primaquine 15 mg. daily for 14 days) for treatment of P. vivax has not been changed over the time. There is only one local malaria clinic in the area. People rarely seek treatment outside; thus almost all clinical malaria cases can be detected at the malaria clinic. All malaria cases were based on microscopic diagnosis.
Census and geographical data
Detailed demography data of all residents were obtained through active surveillance surveys conducted by staff of the malaria clinic in 1998, 2001, and again every three months from 2003 to 2006. A linear trend of population growth was applied to year 2000 and year 2002, when detailed census was not available. These census data were used to form a dynamic cohort of 4,380 residents between 1999 and 2006.
Geographic locations of houses, roads, stream, and the malaria clinic were obtained from a geographic survey in 2005 using Garmin III+ handheld Global Positioning System (GPS) receivers with accuracy within 15 meters. Coordinates of these locations and their attribute data of household members and individual malaria occurrence were entered into the ArcGIS 9.0 software to create a geo-referenced database and a map for the study area (Figure 1). Among the 4,380 individuals recorded in the census, 3,562 individuals who had geographical location data were included in the dynamic cohort for the study. People with missing location data were likely those who came from other areas with lower risk of malaria infection in Thailand and had probably stayed in the area temporarily for work, according to their demographical profiles. Although illegal migration from neighbouring country is possible in this area, the number of migrants is expected to be small, because of the geographical limitation for transportation, and a close monitoring by military troops. The study was approved by the Ethical Committee of the Faculty of Tropical Medicine at Mahidol University, Thailand, and the Institutional Review Board of the University of Maryland, School of Medicine.
Information regarding individual malaria clinical episodes was obtained from records of the Rajanagarindra Tropical Disease International Center (RTIC), the local malaria clinic, between 1999 and 2006. Additional malaria cases, both symptomatic and asymptomatic, were obtained from the routine active surveillance, which began in 2003. All malaria diagnoses were microscopically confirmed by well-trained staff at the clinic. Recrudescence and relapse episodes were defined as repeat P. falciparum malaria attacks within 30 consecutive days or repeat P. vivax attacks within 90 days after the initial episode, respectively. Recrudescence and relapse episodes were considered as a part of the initial episode and were not counted as new malaria infections.
Temporal (within-individual) variables
Mean monthly minimum/maximum temperature, mean monthly humidity, and monthly amount of rainfall, recorded daily at the malaria clinic, were used to determine the seasonality effect on the temporal change of individual malaria risk. The effect of the routine active surveillance and the effect of artemisinin-mefloquine combination therapy were applied to the period beginning in years 2003 and 2005, respectively. Residual spraying programme was the main vector control in the area, which conducted twice a year in February and August, months after the observed peak malaria incidence. The impact of the vector control is expected to be less, because of the delayed timing of the implementation. In addition, the pattern of vector control programmes did not change over the study period. Therefore, variables regarding vector control were not included in the study.
Individual demographic characteristics, including age, gender, and an age-gender interaction, were studied. The age variable was categorized into three groups (0-15, 16-50, and 51+ years old), which likely reflects the difference in behavioural exposure to vector. Although the distance from individual house to a stream was measured at household level, the differences in the distance were relatively large among individuals within a hamlet. Therefore, the proximity to a stream was considered and included in the analysis as a variable at the individual-level.
Hamlet characteristics analysed in the study included: proximity to the malaria clinic, previous incidence of malaria in the hamlet, and landscape features. Distance from individual house to the malaria clinic was more likely to be similar among individuals within the same hamlet, but largely different among individuals in other hamlets. This could represent the difference in access to treatment among hamlets. In an area such as this one, where malaria incidence is geographically clustered, the individual risk of contracting malaria disease could depend on the level of infectiousness in neighboring people. Since the malaria parasite usually takes about 30-40 days from mosquito blood feeding on an infectious individual until successful transmission of the parasite and the resulting clinical symptoms in another individual , a one-month lag of the malaria incidence within a hamlet was used to represent the density of human reservoirs in the community that contribute to malaria burden for a particular case. Other lags (0-2 months) were used to assess general clustering that could be due to other factors.
Landscape characteristics of the study area in 2001 and 2005 by hamlet.
Total area (m2)
Year of Images
Individual occurrences of both P. falciparum and P. vivax were determined for each month during the period that the people appeared in the census; individual monthly malaria occurrences were then used as repeated outcome measures that nested within each individual. This nested data structure resulted in dependency of outcome and the similarity of characteristics among repeated measures within the same individual or among individuals within the same hamlet, which may lead to an artificially small variance in the population [3, 13, 14]. Therefore, a multilevel analytical approach using a generalized linear mixed model (GLMM) was performed to simultaneously analyse the data at different levels on an individual outcome, while accounting for the non-independence of within-individual and within-hamlet observations, and allowing the baseline effects of variables to vary across individual and hamlet, i.e., the random effects were hamlet and individual intercepts [2–4, 14, 15].
Univariate analysis was initially performed to examine the association between each explanatory variable and individual malaria risk. Significant variables at 0.10 level were considered for inclusion in the multivariate analysis. Because of the collinearity among different categories of landscape feature types or between two temperature variables (minimum and maximum), only one landscape feature type and one temperature variable with the strongest significance level were included in the multivariate model. The variables with the strongest univariate relationships were carried forward. Potential biologically plausible intra-level interaction and cross-level interactions were identified. An interaction was considered important at 0.10 level.
Multivariate generalized linear mixed models were then fitted to identify the most parsimonious model using a backward elimination technique. Only mean monthly humidity and monthly amount of rainfall lagged zero to two months, were not significant in the univariate analysis. Therefore, all other significant variables and interactions from the univariate analysis were included in the full model; variables that had the least significance and did not affect the main variable were progressively removed from the full model. The analysis was performed separately for P. falciparum and P. vivax using SAS (PROC GLMMIX) version 9.1; P. falciparum and P. vivax mixed infection episodes were included in both models. Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were then calculated for all potential risk factors that remain significant after being introduced into the multivariate model.
Demography and overall malaria distribution
Demographic and landscape characteristics of the study population by hamlet.
Total population, N
Range of monthly malaria incidence (per 100 persons)
The incidence of both P. falciparum and P. vivax varied across place and time (Table 2). Within the hamlets, the peak monthly incidence (per 100 persons) varied from 4.06 (hamlet D) to 10.57 (hamlet G) for P. falciparum, and from 1.69 (Hamlet C) to 4.65 (hamlet G) for P. vivax.
Temporal risk factors
Adjusted odds ratios (ORs) and 95% confidence intervals (CI) for potential malaria risk factors by Plasmodium species, longitudinal data from 1999 to 2006.
Mean minimum temperature (1°c)
Passive surveillance only
Presence of Active surveillance
Active surveillance + ACT use for P. falciparum
Light forest cover area (1% increase)
Distance to a clinic (1 km increase)
1-month lag incidence of P. falciparum/P. vivax per 100 persons
Covariance of random effects
Individual-level risk factors
The risk of both P. falciparum and P. vivax attack varied with individual age and gender. Male children had the highest risk of contracting malaria, as compared to other age and gender groups. In general, the malaria risk decreased with age for both males and females; the age effect was stronger among females than males. Distance from individual house to a stream was not associated with malaria risk in this population.
Hamlet-level risk factors
The risk of contracting P. falciparum and P. vivax for an individual was significantly affected by the level of P. falciparum and P. vivax incidence within the hamlet to which the individual belongs (Table 3). An increase in the one-month lag hamlet incidence of P. falciparum and P. vivax by only 1 per 100 persons resulted in 1.14 and 1.34 times increase the risk of malaria among people in the particular hamlet. Other time lags were not statistically associated with malaria risk. The association between distance to the malaria clinic and malaria risk was significant only for P. falciparum. The risk of P. falciparum infection increased by 1.13 times for every one kilometer increase in the distance from house to the malaria clinic.
Although the distribution of vegetation types varied across hamlets and time, more than half of each hamlet was covered by forest (Table 1). Since light forest is an important mosquito habitat and showed statistical significance in the univariate analysis, the percentage of light forest cover area was selected for the multivariate models. However, the multivariate analysis revealed that light forest cover was a significant risk factor only for P. falciparum. The risk of P. falciparum attack among people in a hamlet increased by 1.03 for every 1% increase in the hamlet's light forest cover area (Table 3).
None of the cross-level interactions examined in the analysis was significant. The effect of the one-month lag hamlet incidence on an individual malaria risk did not vary significantly by the distance from house to stream, presence of the active surveillance, and individual age-gender profile. The remaining random effect components revealed that the baseline malaria risk varied among hamlets even after controlling for the variables in the model; this between-hamlet variation was larger regarding the risk for P. falciparum than for P. vivax.
Malaria occurrences are not randomly distributed across space and time . This variation is likely influenced by the combined effect of factors that characterize individuals and areas . Findings of the study show that factors at both the community-level and individual level are important in understanding the variation of malaria risk among individuals. In addition, temporal changes in the community factors, e.g., seasonal variation and control intervention programmes, can have a major impact on individual malaria outcome.
The relationship of malaria incidence with monthly minimum temperature rather than rainfall may be unique to this wet, higher altitude area. While the optimal temperature for the development of both vector and parasite is between 25°C and 30°C, the lower temperature during dry season may jeopardize the transmission capability of mosquitoes [17–19]. Since P. vivax is more tolerant at a relatively low temperature condition, the effect of temperature would be expected to be less for P. vivax than P. falciparum, which is consistent with the study findings. This may provide opportunities for new strategies that target interventions to eliminate transmission during these periods when temperature favors success. It may also raise concerns about future failure of control programmes in such regions if warming climate occurs even without changes in rainfall.
Malaria control interventions were associated with a substantial impact on the inter-annual reduction in malaria risk in this population, after adjusting for the temperature effect. Routine active surveillance allows detection of asymptomatic cases, which are the important infectious reservoirs of malaria [20–22]. In addition, symptomatic patients can be detected and treated earlier during active surveillance than when passive surveillance is operating alone . The resulting of reduction in both the number of reservoir hosts and in an individual's infectious period could both decrease infection pressure in a hamlet.
The finding of the effectiveness of artemisinin-based combination therapy (ACT) on P. falciparum occurrence is consistent with research conducted in other areas [23–25]. Artemisinin has been shown to be effective in killing both the asexual stages and the immature sexual stages of P. falciparum parasites, which consequentially prevents onward transmission [26–29]. Although ACT was used only for treatment of P. falciparum, a substantial reduction in P. vivax incidence was also observed during the ACT use period; this could be possibly explained by the additional effect of artesunate in killing asexual P. vivax in patients who initially had mixed infection. Mixed infection is likely to be undetected using microscopy . In Thailand, using molecular techniques, mixed P. falciparum and P. vivax infections have been reported in about 60% of clinical malaria patients, and when it presents, P. falciparum generally dominates . Although ACT has no reported impact on eliminating P. vivax hypnozoites, the liver stage parasite that causes relapse, a clinical trial conducted in Thailand has shown that about 50% of P. vivax patients who received either 5- or 7-day artesunate treatment remained parasite-free at day 28 after the treatment . However, the effect of ACT on reducing subsequent P.vivax reappearance among submicroscopic mixed infection patients is still unclear.
The effect of age and gender on malaria incidence in low transmission settings varies across areas [21, 22, 32, 33]. Unlike areas with high malaria transmission, an increased risk of malaria attack among children in malaria low transmission areas could be easily attributable to their lack of development of immunity, since exposure and clinical episodes are uncommon in all age groups [1, 32]. The pattern of age-gender distribution of malaria risk may, in part, be due to behavioural exposure to vector or to other unmeasured variables, such as intrinsic differences in immune function or hormonal response among different age groups and genders [34, 35]. Future work to explore this pattern, including immunological tests, is needed in hypo-endemic areas.
In this study, the risk of malaria attack was not significantly different for individuals living at variable locations relative to a stream. Although an association between topographical characteristics and malaria incidence has been reported in many areas, these observations are generally where there are large variations in attributes of house locations [21, 36–38]. For example, an increased risk of malaria was found to be associated with houses located farther than 500 or 1,000 meters from a river [21, 36, 37]. However, in this study area, the mean distance from an individual house to a stream was about 200 meters with a range of 200 to 500 meters. This relatively small variation may mean that vector abundance is similar among houses. The hamlet's light forest cover area had a marginal effect on the risk of P. falciparum attack but no effect on the risk of P. vivax attack. There are differences in the preferred habitats of Anopheles vector species in Thailand. An. minimus, a predominant vector in Thailand, is commonly found close to stream margins in forested and foothill areas [39–41]. However, the association between hamlets' light forest area and malaria risk was still uncertain due to limited number of landscape data for comparison at hamlet-level. Future research with wider spatial and temporal coverage is needed to understand which environments might favor transmission.
Malaria transmission directly depends on the presence of a human reservoir as well as the level of vector-human contact [1, 42]. While the factors most commonly found to be associated with vector abundance were relatively stable across the area, changes in the number of infectious human reservoirs in the community could potentially affect transmission probabilities for individuals in the population [43, 44]. For high transmission areas, stable areas of higher and lower incidence have been associated with spatially identifiable transmission and control factors. However, in low transmission areas where the majority of cases are quickly treated, other factors, such as immigrant cases or individual risk behaviours might be more important. In this study, the addition of one human reservoir per 100 persons in a hamlet resulted in 1.14 and 1.34 times higher risk for contracting P. falciparum and P. vivax, respectively, among individuals who lived in the hamlet. Spatial variation in level of gametocyte carriage in the population may have a major role in defining risk for malaria transmission in low endemicity areas.
Gametocyte carriers are vital for sustaining the disease in a population. However, number of humans available to infect mosquitoes may not be a limiting factor in high endemic regions. Interventions that have a strong community-level effect, particularly early detection and treatment to decrease number and duration of gametocyte carriage may have a more powerful effect on reducing malaria transmission in hypoendemic regions [18, 23]. The study findings showed that people who lived far from the malaria clinic were more likely to have P. falciparum attacks than those who lived closer. Distance to the malaria clinic may reflect how quickly people receive treatment. Those who live farther may take longer time to seek treatment, which consequently increases the infectious duration. Although the Euclidean distance used in the study was not accounted for the actual route and terrain to the clinic, the pattern of main roads and terrain features of the area suggests that the Euclidean distance and via route distance are likely to be proportionately similar.
Results of this study may be subject to misclassification bias. The incidence of malaria in a previous month was used as a proxy for the level of infectious individuals in each hamlet. For malaria infection, especially P. falciparum, infected patients do not always represent an infectious population. While this would bias estimates of incidence for each hamlet, the OR's would be biased toward the null (underestimated) unless the rates of infectious to infected individuals varied systematically between hamlets, which could possibly occur if the pattern of treatment and clearance of parasites differed across hamlets. Misclassification of landscape features was also possible because of the limited resolution of LandSat images. Additionally, land use changes were occurring over this period in several of hamlets, which can have variable effects on vector dynamics. However, characterizing spatial attributes may be less critical for a region with widespread water and vector habitat availability.
Although the one-month lag time used for hamlet incidence was based on the time from parasite uptake from one person until clinical symptoms appear in another individual, this lag time did not account for different durations of infectiousness and the infectivity dynamic among individuals. An individual's infectious period is usually less than one week. However, some individuals may remain infectious up to a month, even after treatment [44, 45]. In addition, recrudescence may prolong the duration of infectiousness; and relapse may result in multiple episodes of infectious period. Individuals who had a long infectious period could continue to infect mosquitoes and be a source for the disease in their hamlets in the next two or three months. However, in this study area, short duration from clinical attack to treatment and the low number of asymptomatic cases found during active surveillance suggest that a prolong individual's duration of infectiousness may be less likely, with an exception in 2003 and 2004 when recrudescence was observed in about 10% to 15% of all P. falciparum malaria cases, due to mefloquine resistance. Additionally, previous higher incidence in a hamlet may simply be a proxy for a higher risk in location where malaria is generally found. Findings from the preliminary analysis showed that the locations with highest incidence moved over time in this study area. Further, the effect of hamlet incidence became non-significant in the sensitivity analysis using different lag times (zero and two months lag).
To study the epidemiology of malaria, one must consider the relationship among factors that characterize time, person, and place. In this study, potential malaria risk factors at temporal-level, individual-level, and community-level were simultaneously examined. The 8-year longitudinal data used in the study allowed us to determine the effect of temporal and spatial changes over time. Unlike ecological studies where inferences are drawn on the basis of aggregated outcomes for a group, the individually specified, hierarchical outcomes used in this study provide more valid inferences regarding malaria. Results of this study provide new insight into the malaria epidemiology in a low malaria transmission area, where malaria elimination is feasible. Moreover, similar patterns of P. falciparum and P. vivax risk factors found in the study suggest that a uniform intervention could have an effect on both P. falciparum and P. vivax incidence. However, further research is needed to investigate the effects of ACT on P. vivax among individuals with submicroscopic mixed infection.
The incidence within a hamlet can be a good predictor for individual risk of malaria in a subsequent month; therefore, a targeted malaria monitoring and effective surveillance system could be keys for timely implementation of malaria control programmes. Also, effective intervention programmes that aim to reduce gametocyte carriage could have a major impact on interrupting the malaria transmission in the area.
We are grateful to Dr Patricia Langenberg and Dr Christopher V. Plowe (Department of Medicine, University of Maryland, Baltimore) and Dr David L. Smith (Department of Biology/Emerging Pathogen Institute, University of Florida) for their help and advice in the study project. We also thank staff of Rajanagarindra Tropical Disease International Center, Suan Phung, Ratchaburi, Thailand for their help and support in the field work. We wish to acknowledge financial support of the Faculty of Tropical Medicine, Mahidol University.
- Breman JG: The ears of the hippopotamus: Manifestations, determinants, and estimates of the malaria burden. Am J Trop Med Hyg. 2001, 64: 1-11.PubMed
- Mauny F, Viel JF, Handschumacher P, Sellin B: Multilevel modelling and malaria: A new method for an old disease. Int J Epidemiol. 2004, 33: 1337-1344. 10.1093/ije/dyh274.View ArticlePubMed
- Diez Roux AV, Aiello AE: Multilevel analysis of infectious diseases. J Infect Dis. 2005, 191 (Suppl 1): S25-33. 10.1086/425288.View ArticlePubMed
- Greenland S: Ecologic versus individual-level sources of bias in ecologic estimates of contextual health effects. Int J Epidemiol. 2001, 30: 1343-1350. 10.1093/ije/30.6.1343.View ArticlePubMed
- Diez-Roux AV: Bringing context back into epidemiology: Variables and fallacies in multilevel analysis. Am J Public Health. 1998, 88: 216-222. 10.2105/AJPH.88.2.216.PubMed CentralView ArticlePubMed
- World Health Organization and UNICEF: World malaria report. 2005, Accessed 04/09, 2007., [http://whqlibdoc.who.int/publications/2005/9241593199_eng.pdf]
- Guerin PJ, Olliaro P, Nosten F, Druilhe P, Laxminarayan R, Binka F, Kilama WL, Ford N, White NJ: Malaria: Current status of control, diagnosis, treatment, and a proposed agenda for research and development. Lancet Infect Dis. 2002, 2: 564-573. 10.1016/S1473-3099(02)00372-9.View ArticlePubMed
- Drakeley C, Sutherland C, Bousema JT, Sauerwein RW, Targett GA: The epidemiology of Plasmodium falciparum gametocytes: Weapons of mass dispersion. Trends Parasitol. 2006, 22: 424-430. 10.1016/j.pt.2006.07.001.View ArticlePubMed
- Abdel-Wahab A, Abdel-Muhsin AM, Ali E, Suleiman S, Ahmed S, Walliker D, Babiker HA: Dynamics of gametocytes among Plasmodium falciparum clones in natural infections in an area of highly seasonal transmission. J Infect Dis. 2002, 185: 1838-1842. 10.1086/340638.View ArticlePubMed
- Nacher M, Carrara VI, McGready R, Ashley E, Nguen JV, Thwai KL, Looareesuwan S, Nosten F: Seasonal fluctuations in the carriage of Plasmodium vivax gametocytes in Thailand. Ann Trop Med Parasitol. 2004, 98: 115-120. 10.1179/000349804225003145.View ArticlePubMed
- Phimpraphi W, Paul RE, Yimsamran S, Puangsa-art S, Thanyavanich N, Maneeboonyang W, Prommongkol S, Sornklom S, Chaimungkun W, Chavez IF, Blanc H, Looareesuwan S, Sakuntabhai A, Singhasivanon P: Longitudinal study of Plasmodium falciparum and Plasmodium vivax in a Karen population in Thailand. Malar J. 2008, 7: 99-10.1186/1475-2875-7-99.PubMed CentralView ArticlePubMed
- Sinden RE, Gilles HM: The malaria parasites. Essential Malariology. Edited by: Warrell DA, Gilles HM. 2002, London, UK: Arnold, 8-34. Fourth
- Greenland S: Principles of multilevel modelling. Int J Epidemiol. 2000, 29: 158-167. 10.1093/ije/29.1.158.View ArticlePubMed
- Fitzmaurice GM, Laird NM, Ware JH: Applied Longitudinal Analysis. 2004, New Jersey, U.S.A.: John Wiley & Sons, Inc
- Greenland S: When should epidemiologic regressions use random coefficients?. Biometrics. 2000, 56: 915-921. 10.1111/j.0006-341X.2000.00915.x.View ArticlePubMed
- Carter R, Mendis KN, Roberts D: Spatial targeting of interventions against malaria. Bull World Health Organ. 2000, 78: 1401-1411.PubMed CentralPubMed
- Shiff C: Integrated approach to malaria control. Clin Microbiol Rev. 2002, 15: 278-293. 10.1128/CMR.15.2.278-293.2002.PubMed CentralView ArticlePubMed
- Global Malaria Programme, World Health Organization: Malaria elimination: A field manual for low and moderate endemic countries. [http://malaria.who.int/docs/elimination/MalariaElimination_BD.pdf]
- Snow RW, Gilles HM: The epidemiology of malaria. Essential Malariology. Edited by: Warrell DA, Gilles HM. 2002, London, UK: Arnold, 85-85-106.
- Branch O, Casapia WM, Gamboa DV, Hernandez JN, Alava FF, Roncal N, Alvarez E, Perez EJ, Gotuzzo E: Clustered local transmission and asymptomatic Plasmodium falciparum and Plasmodium vivax malaria infections in a recently emerged, hypoendemic Peruvian amazon community. Malar J. 2005, 4: 27-10.1186/1475-2875-4-27.PubMed CentralView ArticlePubMed
- Oesterholt MJ, Bousema JT, Mwerinde OK, Harris C, Lushino P, Masokoto A, Mwerinde H, Mosha FW, Drakeley CJ: Spatial and temporal variation in malaria transmission in a low endemicity area in northern Tanzania. Malar J. 2006, 5: 98-10.1186/1475-2875-5-98.PubMed CentralView ArticlePubMed
- Erhart A, Thang ND, Bien TH, Tung NM, Hung NQ, Hung LX, Tuy TQ, Speybroeck N, Cong LD, Coosemans M, D'Alessandro U: Malaria epidemiology in a rural area of the Mekong delta: A prospective community-based study. Trop Med Int Health. 2004, 9: 1081-1090. 10.1111/j.1365-3156.2004.01310.x.View ArticlePubMed
- Carrara VI, Sirilak S, Thonglairuam J, Rojanawatsirivet C, Proux S, Gilbos V, Brockman A, Ashley EA, McGready R, Krudsood S, Leemingsawat S, Looareesuwan S, Singhasivanon P, White N, Nosten F: Deployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: The Tak malaria initiative. PLoS Med. 2006, 3: e183-10.1371/journal.pmed.0030183.PubMed CentralView ArticlePubMed
- Suputtamongkol Y, Chindarat S, Silpasakorn S, Chaikachonpatd S, Lim K, Chanthapakajee K, Kaewkaukul N, Thamlikitkul V: The efficacy of combined mefloquine-artesunate versus mefloquine-primaquine on subsequent development of Plasmodium falciparum gametocytemia. Am J Trop Med Hyg. 2003, 68: 620-623.PubMed
- Nosten F, White NJ: Artemisinin-based combination treatment of falciparum malaria. Am J Trop Med Hyg. 2007, 77: 181-192.PubMed
- White NJ: Qinghaosu (artemisinin): The price of success. Science. 2008, 320: 330-334. 10.1126/science.1155165.View ArticlePubMed
- Chotivanich K, Sattabongkot J, Udomsangpetch R, Looareesuwan S, Day NP, Coleman RE, White NJ: Transmission-blocking activities of quinine, primaquine, and artesunate. Antimicrob Agents Chemother. 2006, 50: 1927-1930. 10.1128/AAC.01472-05.PubMed CentralView ArticlePubMed
- Pukrittayakamee S, Chotivanich K, Chantra A, Clemens R, Looareesuwan S, White NJ: Activities of artesunate and primaquine against asexual-and sexual-stage parasites in falciparum malaria. Antimicrob Agents Chemother. 2004, 48: 1329-1334. 10.1128/AAC.48.4.1329-1334.2004.PubMed CentralView ArticlePubMed
- Price RN, Nosten F, Luxemburger C, ter Kuile FO, Paiphun L, Chongsuphajaisiddhi T, White NJ: Effects of artemisinin derivatives on malaria transmissibility. Lancet. 1996, 347: 1654-1658. 10.1016/S0140-6736(96)91488-9.View ArticlePubMed
- Mayxay M, Pukrittayakamee S, Newton PN, White NJ: Mixed-species malaria infections in humans. Trends Parasitol. 2004, 20: 233-240. 10.1016/j.pt.2004.03.006.View ArticlePubMed
- Silachamroon U, Krudsood S, Treeprasertsuk S, Wilairatana P, Chalearmrult K, Mint HY, Maneekan P, White NJ, Gourdeuk VR, Brittenham GM, Looareesuwan S: Clinical trial of oral artesunate with or without high-dose primaquine for the treatment of vivax malaria in Thailand. Am J Trop Med Hyg. 2003, 69: 14-18.PubMed CentralPubMed
- Incardona S, Vong S, Chiv L, Lim P, Nhem S, Sem R, Khim N, Doung S, Mercereau-Puijalon O, Fandeur T: Large-scale malaria survey in Cambodia: Novel insights on species distribution and risk factors. Malar J. 2007, 6: 37-10.1186/1475-2875-6-37.PubMed CentralView ArticlePubMed
- Shekalaghe SA, Bousema JT, Kunei KK, Lushino P, Masokoto A, Wolters LR, Mwakalinga S, Mosha FW, Sauerwein RW, Drakeley CJ: Submicroscopic Plasmodium falciparum gametocyte carriage is common in an area of low and seasonal transmission in Tanzania. Trop Med Int Health. 2007, 12: 547-553.View ArticlePubMed
- Baird JK: Age-dependent characteristics of protection v. susceptibility to Plasmodium falciparum. Ann Trop Med Parasitol. 1998, 92: 367-390. 10.1080/00034989859366.View ArticlePubMed
- Cernetich A, Garver LS, Jedlicka AE, Klein PW, Kumar N, Scott AL, Klein SL: Involvement of gonadal steroids and gamma interferon in sex differences in response to blood-stage malaria infection. Infect Immun. 2006, 74: 3190-3203. 10.1128/IAI.00008-06.PubMed CentralView ArticlePubMed
- Staedke SG, Nottingham EW, Cox J, Kamya MR, Rosenthal PJ, Dorsey G: Short report: Proximity to mosquito breeding sites as a risk factor for clinical malaria episodes in an urban cohort of Ugandan children. Am J Trop Med Hyg. 2003, 69: 244-246.PubMed
- Hakre S, Masuoka P, Vanzie E, Roberts DR: Spatial correlations of mapped malaria rates with environmental factors in Belize, Central America. Int J Health Geogr. 2004, 3: 6-10.1186/1476-072X-3-6.PubMed CentralView ArticlePubMed
- Ernst KC, Adoka SO, Kowuor DO, Wilson ML, John CC: Malaria hotspot areas in a highland Kenya site are consistent in epidemic and non-epidemic years and are associated with ecological factors. Malar J. 2006, 5: 78-10.1186/1475-2875-5-78.PubMed CentralView ArticlePubMed
- Sithiprasasna R, Ugsang DM, Honda K, Jones JW, Singhasivanon P: Ikonos-derived malaria transmission risk in northwestern Thailand. Southeast Asian J Trop Med Public Health. 2005, 36: 14-22.PubMed
- Garros C, Van Bortel W, Trung HD, Coosemans M, Manguin S: Review of the minimus complex of anopheles, main malaria vector in Southeast Asia: From taxonomic issues to vector control strategies. Trop Med Int Health. 2006, 11: 102-114. 10.1111/j.1365-3156.2005.01536.x.View ArticlePubMed
- Kengluecha A, Rongnoparut P, Boonsuepsakul S, Sithiprasasna R, Rodpradit P, Baimai V: Geographical distribution of Anopheles minimus species A and C in western Thailand. J Vector Ecol. 2005, 30: 225-230.PubMed
- McKenzie FE: Why model malaria?. Parasitol Today. 2000, 16: 511-516. 10.1016/S0169-4758(00)01789-0.View ArticlePubMed
- Diez Roux AV: The study of group-level factors in epidemiology: Rethinking variables, study designs, and analytical approaches. Epidemiol Rev. 2004, 26: 104-111. 10.1093/epirev/mxh006.View ArticlePubMed
- Tangpukdee N, Krudsood S, Srivilairit S, Phophak N, Chonsawat P, Yanpanich W, Kano S, Wilairatana P: Gametocyte clearance in uncomplicated and severe Plasmodium falciparum malaria after artesunate-mefloquine treatment in Thailand. Korean J Parasitol. 2008, 46: 65-70. 10.3347/kjp.2008.46.2.65.PubMed CentralView ArticlePubMed
- Piyaphanee W, Krudsood S, Silachamroon U, Pornpininworakij K, Danwiwatdecha P, Chamnachanan S, Wilairatana P, Looareesuwan S: Travelers' malaria among foreigners at the hospital for tropical diseases, Bangkok, Thailand - a 6-year review (2000-2005). Korean J Parasitol. 2006, 44: 229-232. 10.3347/kjp.2006.44.3.229.PubMed CentralView ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.